You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 25, 2026
Sale
Calculated transaction value
$171.93K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 24, 2026
Public filing date
Sep 25, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$472.21
Sep 24, 2026
First close after public filing
$485.54
Sep 28, 2026
30-day return after filing
+22.1%
Through Oct 26, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 360 shares @ $477.58
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000149
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$5.62M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $300.63K |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $1.23M |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $1.02M |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $274.18K |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $133.42K |
| United Therapeutics Corp UTHR Current | Sale | Sep 24, 2026 | $171.93K |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $287.71K |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $19.21K |
| United Therapeutics Corp UTHR | Exercise | Sep 24, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Sep 24, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $207.14K |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $152.11K |
| United Therapeutics Corp UTHR | Sale | Sep 24, 2026 | $708.34K |